Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.

Wohl DA, Kendall MA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Benson C, Keiser P, van der Horst C, Jacobson MA; A5030 Study Team.

PLoS One. 2013 Nov 15;8(11):e78676. doi: 10.1371/journal.pone.0078676. eCollection 2013.

PMID:
24260125
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.

Smith KY, Tierney C, Mollan K, Venuto CS, Budhathoki C, Ma Q, Morse GD, Sax P, Katzenstein D, Godfrey C, Fischl M, Daar ES, Collier AC; AIDS Clinical Trials Group 5202 Study Team.

Clin Infect Dis. 2014 Feb;58(4):555-63. doi: 10.1093/cid/cit747. Epub 2013 Nov 18.

PMID:
24253247
[PubMed - in process]
3.

Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.

Sax PE, Tierney C, Collier AC, Daar ES, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Feinberg J, Tashima K, Murphy RL, Fischl MA; AIDS Clinical Trials Group Study A5202 Team.

J Infect Dis. 2011 Oct 15;204(8):1191-201. doi: 10.1093/infdis/jir505.

PMID:
21917892
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

Daar ES, Tierney C, Fischl MA, Sax PE, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Pappa KA, Woodward WC, Patterson K, Bolivar H, Benson CA, Collier AC; AIDS Clinical Trials Group Study A5202 Team.

Ann Intern Med. 2011 Apr 5;154(7):445-56. doi: 10.7326/0003-4819-154-7-201104050-00316. Epub 2011 Feb 14.

PMID:
21320923
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Progress in the treatment of blunt thoracic aortic injury: 12-year single-institution experience.

Estrera AL, Gochnour DC, Azizzadeh A, Miller CC 3rd, Coogan S, Charlton-Ouw K, Holcomb JB, Safi HJ.

Ann Thorac Surg. 2010 Jul;90(1):64-71. doi: 10.1016/j.athoracsur.2010.03.053.

PMID:
20609750
[PubMed - indexed for MEDLINE]
6.

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.

Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, Hughes MD; ALLRT team.

AIDS. 2010 Jul 31;24(12):1867-76. doi: 10.1097/QAD.0b013e32833adbcf.

PMID:
20467286
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Sax PE, Tierney C, Collier AC, Fischl MA, Mollan K, Peeples L, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Koletar SL, Johnson VA, Geiseler PJ, Daar ES; AIDS Clinical Trials Group Study A5202 Team.

N Engl J Med. 2009 Dec 3;361(23):2230-40. doi: 10.1056/NEJMoa0906768. Epub 2009 Dec 1.

PMID:
19952143
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Traumatic right ventricular rupture after recent sternotomy.

Gochnour D, Safi HJ, Estrera AL.

J Card Surg. 2010 Jan-Feb;25(1):46. doi: 10.1111/j.1540-8191.2009.00945.x. Epub 2009 Nov 11. No abstract available.

PMID:
19912436
[PubMed - indexed for MEDLINE]
9.

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

Wohl DA, Kendall MA, Andersen J, Crumpacker C, Spector SA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Lurain N, Jabs D, Benson C, Keiser P, Jacobson MA; A5030 Study Team.

HIV Clin Trials. 2009 May-Jun;10(3):143-52. doi: 10.1310/hct1003-143.

PMID:
19632953
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.

Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, McArthur JC, Robertson K; AIDS Clinical Trials Group 736 Study Team.

AIDS. 2009 Jul 17;23(11):1359-66. doi: 10.1097/QAD.0b013e32832c4152.

PMID:
19424052
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.

Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dubé M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR; AIDS Clinical Trials Group 384 and A5005s Study Teams.

J Infect Dis. 2008 Mar 15;197(6):858-66. doi: 10.1086/528697. Erratum in: J Infect Dis. 2008 Jun 1;197(11):1630.

PMID:
18419350
[PubMed - indexed for MEDLINE]
Free Article
12.

Phase II trial of topotecan in malignant melanoma.

Kraut EH, Walker MJ, Staubus A, Gochnour D, Balcerzak SP.

Cancer Invest. 1997;15(4):318-20.

PMID:
9246152
[PubMed - indexed for MEDLINE]
13.

Clinical and immunological effects of a synthetic Beta-human chorionic-gonadotropin vaccine.

Triozzi P, Gochnour D, Martin E, Aldrich W, Powell J, Kim J, Young D, Lombardi J.

Int J Oncol. 1994 Dec;5(6):1447-53.

PMID:
21559734
[PubMed]
14.

Phase Ib trial of a synthetic beta human chorionic gonadotropin vaccine in patients with metastatic cancer.

Triozzi PL, Martin EW, Gochnour D, Aldrich W.

Ann N Y Acad Sci. 1993 Aug 12;690:358-9. No abstract available.

PMID:
8368755
[PubMed - indexed for MEDLINE]
15.

Immunosuppressive effects of pentostatin.

Kraut EH, Neff JC, Bouroncle BA, Gochnour D, Grever MR.

J Clin Oncol. 1990 May;8(5):848-55.

PMID:
2332771
[PubMed - indexed for MEDLINE]
Free Article
16.

Phase II trial of MVE-II in metastatic malignant melanoma.

Rinehart J, LaForge J, Gochnour D, Neidhart J.

Cancer Immunol Immunother. 1987;24(3):244-6.

PMID:
3496153
[PubMed - indexed for MEDLINE]
17.

A comparison of mitoxantrone and doxorubicin in breast cancer.

Neidhart JA, Gochnour D, Roach R, Hoth D, Young D.

J Clin Oncol. 1986 May;4(5):672-7.

PMID:
3517241
[PubMed - indexed for MEDLINE]
Free Article
18.

A comparative trial of mitoxantrone and doxorubicin in patients with minimally pretreated breast cancer.

Neidhart JA, Gochnour D, Roach RW, Young D, Steinberg JA.

Semin Oncol. 1984 Sep;11(3 Suppl 1):11-4.

PMID:
6385259
[PubMed - indexed for MEDLINE]
19.

A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.

Gagen M, Gochnour D, Young D, Gaginella T, Neidhart J.

J Clin Oncol. 1984 Jun;2(6):696-701.

PMID:
6374059
[PubMed - indexed for MEDLINE]
Free Article
20.

Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.

Neidhart JA, Gochnour D, Roach RW, Steinberg JA, Young D.

Cancer Treat Rev. 1983 Dec;10 Suppl B:41-6. No abstract available.

PMID:
6362877
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk